# Post ts_117606259365899322

- Post ID: `ts_117606259365899322`
- Platform: Truth Social
- Posted: 2026-11-13T00:18:24.093Z (UTC)
- Deleted: no
- Repost: no
- Canonical URL: https://trump.fm/post/ts_117606259365899322
- Analysis page: https://trump.fm/post/ts_117606259365899322/analysis
- Audio narration: https://static.trump.fm/audio/ts_117606259365899322.mp3 (a synthesized voice reading the post text, not a recording)

## Post text

> Lilly breaks ground in Pennsylvania's Lehigh Valley on a $3.5 billion site to make next-generation obesity medicines, the latest of 10 new U.S. sites since 2020: https://investor.lilly.com/news-releases/news-release-details/lilly-breaks-ground-pennsylvanias-lehigh-valley-35-billion-site

## Engagement

- Likes: 19,680
- Reposts: 4,261
- Replies: 1,848
- Views: unknown
- Metrics collected: 2026-11-18T15:01:26.777Z (UTC)

# Analysis

_Machine-generated by trump.fm on 2026-11-13T00:22:34.816Z (UTC): a model's reading of this post, not his words. Its psychological terms describe the language, not a clinical assessment of him._

## A press-release headline, pasted whole

The post copies the title of an Eli Lilly investor-relations release and adds a link. It adds no words of his own: no adjective, no "thanks to me," no tariff reference, and no "President DONALD J. TRUMP" sign-off, which closes four of the five posts from the previous day. The phrasing "the latest of 10 new U.S. sites since 2020" is corporate boilerplate. It also sets the count's start date in 2020, so most of the tally falls before his second term. A Trump-voiced version would more likely have claimed the investment outright ("because of my Tariffs") than left in a timeframe that splits the credit with the Biden years.

**Authorship.** The UTC stamp of 00:18 on November 13 is 7:18 pm Eastern on November 12. He was most likely in Washington, where the same day's posts on the defense reconciliation bill and Chuck Schumer were written. Early evening is a gray zone. What points to staff is the text, not the clock: the sentence is word-for-word corporate copy, with numerals ("$3.5 billion," "10") and a proper place name ("Pennsylvania's Lehigh Valley"). His own posts lean toward round, capitalized figures ("350 Billion Dollar") and drift into commentary. Nothing here drifts.

**What the selection does.** A wordless repost can still make a claim, and this one stands in for a reshoring success story. Its context matters. The midterms had just handed Congress to Democrats, and the previous day's feed held a grievance against the "Radical Democrat Majority," a demand to prosecute the "Seditious Six," and a Hugh Hewitt compliment ("as good as he has ever been") offered as admiration supply. Next to those, the Lilly item supplies good economic news from a swing state after an electoral defeat. That fits a maintenance or reassurance pattern. It does not fit a reaction to injury. The post carries no affect to read for rage, splitting or projection, and the absence of any target means the post can't be read as part of the day's adversarial stream.

**Fact base.** The $3.5 billion Lehigh Valley figure matches Lilly's January 2026 announcement of an injectable obesity-drug plant in Upper Macungie Township, built to make retatrutide and tirzepatide. Lilly said construction would start in 2026, with roughly 850 permanent jobs and production from 2031. The "10 sites since 2020" figure is Lilly's own count. It roughly matches the sites Lilly has announced: Concord and Research Triangle Park in North Carolina, the Lebanon, Indiana complex, Kenosha, Wisconsin, Goochland, Virginia, Houston, Huntsville, and Lehigh Valley. None of the coverage I found dates the groundbreaking ceremony itself, but the release title on Lilly's investor site is the primary source for it.

**Rhetoric.** The only device is implied credit by association: a corporate investment placed in the President's feed with no stated causal link. The post contains no hyperbole, no enemy and no call to action. Fixed-pattern cognitive markers can't be scored, because none of the text is his.

Sources: [BioSpace](https://www.biospace.com/business/eli-lilly-commits-3-5b-to-build-injectable-obesity-drug-plant-in-pa), [Manufacturing.net](https://www.manufacturing.net/operations/news/22959715/eli-lilly-invests-35-billion-to-make-weightloss-medicines-in-pennsylvania), [Chemical Processing](https://chemicalprocessing.com/industrynews/news/55354367/eli-lilly-to-build-35b-drug-manufacturing-site-in-pennsylvania), [Xtalks](https://xtalks.com/eli-lilly-invests-3-5b-in-pennsylvania-to-scale-next%e2%80%91gen-obesity-drug-manufacturing-4641/)

## Fact Verification

| Claim | Verdict | Evidence |
|-------|---------|----------|
| "Lilly is building a $3.5 billion site in Pennsylvania's Lehigh Valley to make next-generation obesity medicines" | **True** | Lilly announced on January 30, 2026 a $3.5 billion injectable obesity-drug plant in Upper Macungie Township, Lehigh Valley, to produce retatrutide and tirzepatide, with construction planned for 2026 and operations from 2031. The groundbreaking headline comes from Lilly's own investor-relations release. |
| "The Lehigh Valley site is the latest of 10 new U.S. sites since 2020" | **Mostly True** | This is Lilly's own count. Announced U.S. sites since 2020 include Concord and Research Triangle Park in North Carolina, the Lebanon, Indiana complex (multiple plants), Kenosha, Wisconsin, Goochland, Virginia, Houston, Huntsville and Lehigh Valley, which comes to about ten depending on how the Lebanon plants are counted. Some coverage instead calls Lehigh Valley the fourth new site since early 2025, a different window. |

Overall Veracity: 90%

## Authorship Analysis

**Aide-Written** (score: 12%)

### Indicators

- Verbatim corporate press-release headline with link
- No signature block, unlike four of five previous-day posts
- Precise figures ($3.5 billion, 10 sites) in corporate register
- Timeframe 'since 2020' left unedited, splitting credit with prior administration
- No commentary, capitalization, or tangent

## Psychological Profile

### Traits

**Big Five:**
- Extraversion: 50%
- Agreeableness: 50%
- Conscientiousness: 60%
- Neuroticism: 20%
- Openness: 40%

Strongest facet: achievement striving (by proxy, via reshoring credit)

**Motives:**
- Agency: 60%
- Communion: 20%

Primary drive: achievement

### Narrative

- **Role:** implicit dealmaker behind reshoring
- **Arc:** neutral
- **Contrasting:** none

### State

**Grandiose State**

**Trigger:** Maintenance (Routine economic-good-news amplification after midterm losses)

Sentiment: +0.50

### Clinical

**Malignant Narcissism:**
- Narcissistic: 10%
- Antisocial: 0%
- Paranoid: 0%
- Sadism: 0%

**Cognitive Complexity:**
- Complexity: 50%

**Parasocial Techniques:**
- Implied credit by association with corporate investment

## Fact Checks (2)

_The model's verdicts from 2026-11-13._

> Lilly is building a $3.5 billion site in Pennsylvania's Lehigh Valley to make next-generation obesity medicines

**TRUE**

Lilly announced on January 30, 2026 a $3.5 billion injectable obesity-drug plant in Upper Macungie Township, Lehigh Valley, to produce retatrutide and tirzepatide, with construction planned for 2026 and operations from 2031. The groundbreaking headline comes from Lilly's own investor-relations release.

Sources: https://www.biospace.com/business/eli-lilly-commits-3-5b-to-build-injectable-obesity-drug-plant-in-pa; https://www.manufacturing.net/operations/news/22959715/eli-lilly-invests-35-billion-to-make-weightloss-medicines-in-pennsylvania

> The Lehigh Valley site is the latest of 10 new U.S. sites since 2020

**MOSTLY TRUE**

This is Lilly's own count. Announced U.S. sites since 2020 include Concord and Research Triangle Park in North Carolina, the Lebanon, Indiana complex (multiple plants), Kenosha, Wisconsin, Goochland, Virginia, Houston, Huntsville and Lehigh Valley, which comes to about ten depending on how the Lebanon plants are counted. Some coverage instead calls Lehigh Valley the fourth new site since early 2025, a different window.

Sources: https://chemicalprocessing.com/industrynews/news/55354367/eli-lilly-to-build-35b-drug-manufacturing-site-in-pennsylvania; https://xtalks.com/eli-lilly-invests-3-5b-in-pennsylvania-to-scale-next%e2%80%91gen-obesity-drug-manufacturing-4641/

Overall Veracity: 90%

## Tags

- reshoring (80%)
- pharmaceuticals (70%)
- pennsylvania (50%)
- press-release-amplification (80%)

## That day

_From trump.fm's machine-generated digest of the day, not his words._

**Trump counts Adam Schiff, "believe it or not," among the lawmakers he says he is working with**

A short, even-tempered day that began Thursday evening with a pasted Eli Lilly headline about a $3.5 billion obesity-drug plant in Pennsylvania. Friday morning went to other people praising him: a clip of border czar Tom Homan calling him "the greatest president in my lifetime," then a fan account's graphic declaring him the best president in American history. After posting nothing through the working day, he came back in the early evening in his own words. He listed more than a dozen lawmakers from both parties he says he is working with, and flagged one of them, longtime foe Adam Schiff, with a "believe it or not." Minutes later he thanked the Coast Guard and first responders after two ships collided in Louisiana, stressing that nobody was killed, and the day's only partisan jab came secondhand, in the Homan clip's swipe at the Biden years.

Full digest for 2026-11-13: https://trump.fm/date/2026-11-13/analysis

## Citation

- APA: Trump, D. J. (2026, November 13). Lilly breaks ground in Pennsylvania's Lehigh... [Social media post]. Truth Social. trump.fm. https://trump.fm/post/ts_117606259365899322
- MLA: Trump, Donald J. "Lilly breaks ground in Pennsylvania's Lehigh Valley on a..." Truth Social, 13 Nov. 2026. trump.fm, https://trump.fm/post/ts_117606259365899322. Accessed 18 Nov. 2026.
- Chicago: Donald J. Trump, "Lilly breaks ground in Pennsylvania's Lehigh Valley on a...," Truth Social, November 13, 2026, archived at trump.fm, https://trump.fm/post/ts_117606259365899322.

## For agents

- Site overview: https://trump.fm/llms.txt
- API specification: https://trump.fm/openapi.json
- MCP server: https://trump.fm/mcp (search and fetch tools, no auth)
- This post as JSON: https://trump.fm/api/posts/ts_117606259365899322
- Analysis as JSON: https://trump.fm/api/analysis/ts_117606259365899322
- All citation formats: https://trump.fm/api/cite/ts_117606259365899322
- Same day: https://trump.fm/date/2026-11-13
- The record alone, without the analysis: https://trump.fm/post/ts_117606259365899322.md?analysis=false

_Markdown view of a trump.fm page. Post, analysis, date, feed, contradictions, search and about pages answer in markdown at their URL with `.md` appended (`/index.md` for the home page), or when sent `Accept: text/markdown`._